Clinical data presented at ASCO 2025 showed an objective response rate (ORR) of 63% among all patients, with a median progression-free survival (PFS) of 7.7 months. Responses were seen across ...

AI models using ultrasound imaging demonstrate superior diagnostic performance for ovarian cancer compared to sonographers, with higher sensitivity and specificity. The study emphasizes the need for ...

These 14 commonly ignored symptoms—unexplained weight change, persistent fatigue, unusual bleeding, new lumps, lingering ...

Here are the top 5 ovarian cancer articles of 2025; stay up-to-date with all the ovarian cancer content from The American ...

Menopause represents a profound systemic shift involving cardiovascular, skeletal, and neurological health, requiring ...

By a News Reporter-Staff News Editor at NewsRx Women’ s Health Daily-- Investigators publish new report on Oncology- Breast Cancer. According to news reporting originating in Goiania, Brazil, by ...

Preliminary research indicates cannabis compounds cannabidiol and Δ9-tetrahydrocannabinol could have potential in treating ...

Lactating armpits, deadly burgers, and the world's nosiest parasite are some of this year's most bizzaro medical tales.

CBD and THC kill ovarian cancer cells at doses that largely spare normal cells, disrupting survival pathways through multiple ...

A recent study has found that two cannabis derivatives may aid in ovarian cancer treatment. The research indicates that CBD ...

Since acquiring exclusive rights to launch and commercialise catumaxomab in 2024, in partnership with Lindis Biotech, Pharmanovia has been committed to ensuring people have access to a treatment that ...

Impulsive, anxious, overheated, scatter-brained, depressed and in pain are just some of the terms that many women use to describe themselves when they reach perimenopause, or the years that ...